Your browser does not support iframes.
JERUSALEM--(BUSINESS WIRE)--Mar. 13, 2017--
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a
live audio webcast at the Barclays Global Healthcare Conference in
Live over the Internet – log on to the Web at the address above
and register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s Website at http://ir.tevapharm.com.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading
global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions used by approximately 200 million
patients in 100 markets every day. Headquartered in Israel, Teva is the
world’s largest generic medicines producer, leveraging its portfolio of
more than 1,800 molecules to produce a wide range of generic products in
nearly every therapeutic area. In specialty medicines, Teva has the
world-leading innovative treatment for multiple sclerosis as well as
late-stage development programs for other disorders of the central
nervous system, including movement disorders, migraine, pain and
neurodegenerative conditions, as well as a broad portfolio of
respiratory products. Teva is leveraging its generics and specialty
capabilities in order to seek new ways of addressing unmet patient needs
by combining drug development with devices, services and technologies.
Teva's net revenues in 2016 were $21.9 billion. For more information,
View source version on businesswire.com: http://www.businesswire.com/news/home/20170313005745/en/
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.IR Contacts:United StatesKevin
C. Mannix, 215-591-8912orRan Meir, 215-591-3033orIsraelTomer
Amitai, 972 (3) 926-7656orPR Contacts:IsraelIris
Beck Codner, 972 (3) 926-7246orUnited StatesDenise